Literature DB >> 18407140

Circulating binding proteins for the insulinlike growth factors.

R C Baxter1.   

Abstract

Six distinct insulinlike growth factor-binding proteins (IGFBP-1 to IGFBP-6) of core molecular mass 20-30 II have been identified, of which one, IGFBP-3, carries most o f the circulating IGF-I and IGF-II in ternary complexes that also contain an acid-labile glycoprotein subunit. Although the role of circulating IGFBP-3 in IGF stabilization and transport is becoming increasingly well understood, the functions of the other IGFBPs in the circulation are less clear, and some redundancy of function is possible. IGFBP-l, which is metabolically regulated by insulin and carbohydrates, may act as a counterregulator in blood glucose regulation and could also be important in targeting IGF delivery from the circulation to the tissues, while recent studies of IGFBP-2 physiology suggest that this protein may function as an additional IGF carrier when IGFBP-3 levels are inadequate. Research into the roles of circulating IGFBP-4, -5, and -6 is, as yet, poorly developed and will depend on the ready availability of analytical methods for these proteins.

Entities:  

Year:  1993        PMID: 18407140     DOI: 10.1016/1043-2760(93)90085-s

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  25 in total

1.  Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women.

Authors:  T Yamaguchi; M Kanatani; M Yamauchi; H Kaji; T Sugishita; D J Baylink; S Mohan; K Chihara; T Sugimoto
Journal:  Calcif Tissue Int       Date:  2006-01-06       Impact factor: 4.333

Review 2.  Assessment of serum IGF-I concentrations in the diagnosis of isolated childhood-onset GH deficiency: a proposal of the Italian Society for Pediatric Endocrinology and Diabetes (SIEDP/ISPED).

Authors:  G Federico; M E Street; M Maghnie; M Caruso-Nicoletti; S Loche; S Bertelloni; S Cianfarani
Journal:  J Endocrinol Invest       Date:  2006-09       Impact factor: 4.256

Review 3.  General aspects of insulin-like growth factor binding proteins.

Authors:  K Chan; E M Spencer
Journal:  Endocrine       Date:  1997-08       Impact factor: 3.633

Review 4.  Articular cartilage destruction in experimental inflammatory arthritis: insulin-like growth factor-1 regulation of proteoglycan metabolism in chondrocytes.

Authors:  P J Verschure; C J Van Noorden; J Van Marle; W B Van den Berg
Journal:  Histochem J       Date:  1996-12

5.  Involvement of insulin-like growth factor-binding protein-3 in the effects of histone deacetylase inhibitor MS-275 in hepatoma cells.

Authors:  Wen Hui Lin; Janet L Martin; Deborah J Marsh; Michelle M Jack; Robert C Baxter
Journal:  J Biol Chem       Date:  2011-07-07       Impact factor: 5.157

Review 6.  Insulin-like growth factors and their binding proteins: Potential relevance to reproductive physiology.

Authors:  Yasunori Yoshimura
Journal:  Reprod Med Biol       Date:  2003-03-25

Review 7.  Nuclear actions of insulin-like growth factor binding protein-3.

Authors:  Robert C Baxter
Journal:  Gene       Date:  2015-06-12       Impact factor: 3.688

8.  Serum levels of insulin-like growth factors (IGF-I and IGF-II) and their binding protein (IGFBP-3) are not elevated in pancreatic cancer.

Authors:  J D Evans; M C Eggo; I A Donovan; S R Bramhall; J P Neoptolemos
Journal:  Int J Pancreatol       Date:  1997-10

9.  Insulin-like growth factor binding protein-3 (IGFBP-3): Novel ligands mediate unexpected functions.

Authors:  Robert C Baxter
Journal:  J Cell Commun Signal       Date:  2013-08       Impact factor: 5.782

Review 10.  IGF binding proteins in cancer: mechanistic and clinical insights.

Authors:  Robert C Baxter
Journal:  Nat Rev Cancer       Date:  2014-04-10       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.